Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia ; volume:16 ; number:1 ; day:3 ; month:7 ; year:2018 ; pages:1-10 ; date:12.2018
BMC medicine ; 16, Heft 1 (3.7.2018), 1-10, 12.2018
- Urheber
-
Shoukat, Affan
- Beteiligte Personen und Organisationen
-
Vilches, Thomas
Moghadas, Seyed M.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1091-x
- URN
-
urn:nbn:de:101:1-2018090118182909251491
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shoukat, Affan
- Vilches, Thomas
- Moghadas, Seyed M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Computer aided selection of candidate vaccine antigens
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
Computer aided selection of candidate vaccine antigens
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
Exploring the immunogenicity of an insect-specific virus vectored Zika vaccine candidate
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
Live Zika virus chimeric vaccine candidate based on a yellow fever 17-D attenuated backbone
Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Case report: microcephaly associated with Zika virus infection, Colombia
Vaccine Development for Zika Virus—Timelines and Strategies
A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone